Sidra Bibi

Sidra Bibi

Auto-generated profile, based on publicly available information

Sidra Bibi

Department of Biology, The Islamia University of Bahawalpur, Bahawalnagar Campus 62300, Pakistan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2023 in Journal of Materials Chemistry B
Verified
Journal Article
Open access
PDF file
MGMuhammad Ghani
Muhammad Ghani
AIAmbreen Iqbal
Ambreen Iqbal
HGHammad Ghani
Hammad Ghani
SBSidra Bibi
Sidra Bibi
ZWZixun Wang
Zixun Wang
RPRen-Jun Pei
Ren-Jun Pei
CRISPR/Cas systems are novel gene editing tools with tremendous capacity and accuracy for gene editing and hold great potential for therapeutic genetic manipulation. However, the lack of safe and efficient delivery methods for CRISPR/Cas and its guide RNA hinders their wide adoption for therapeutic applications. To this end, there is an increasing demand for safe, efficient, precise, and non-pathogenic delivery approaches, both in vitro and in vivo. With the convergence of nanotechnology and biomedicine, functional nanocomposites have demonstrated unparalleled sophistication to overcome the limits of CRISPR/Cas delivery. The tunability of the physicochemical properties of nanocomposites makes it very easy to conjugate them with different functional substances. The combinatorial application of diverse functional materials in the form of nanocomposites has shown excellent properties for CRISPR/Cas delivery at the target site with therapeutic potential. The recent highlights of selective organ targeting and phase I clinical trials for gene manipulation by CRISPR/Cas after delivery through LNPs are at the brink of making it to routine clinical practice. Here we summarize the recent advances in delivering CRISPR/Cas systems through nanocomposites for targeted delivery and therapeutic genome editing.